ENTITY
Livzon Pharmaceutical Group

Livzon Pharmaceutical Group (1513 HK)

108
Analysis
Health Care • China
Livzon Pharmaceutical Group is a comprehensive pharmaceutical company engaged in the research, development, production, and sales of various pharmaceutical products. Its portfolio includes chemical drugs, biological drugs, traditional Chinese medicine, and in vitro diagnostic reagents, covering therapeutic areas such as digestion, cardiovascular, reproductive endocrinology, and mental/nervous systems. The company was founded in January 1985 and is headquartered in Zhuhai City, Guangdong Province, China.
more
bullish•China Tower
•14 Jan 2019 14:50

HK Connect Discovery Weekly: China Tower, Tencent, New China Life (2019-01-11)

In our Discover HK Connect series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed by...

Logo
714 Views
Share
bearish•WuXi AppTec
•28 Nov 2018 05:57

WuXi AppTech IPO Update: Figuring Out the Right AH Premium

WuXi AppTec Co. Ltd. (WUXI HK) is a leading global pharmaceutical R&D outsourcing service provider and the largest in Asia by revenue in 2017....

Logo
931 Views
Share
bearish•Ascletis Pharma
•22 Jul 2018 16:09

Ascletis Pharma IPO Preview: Drug-Fuelled Euphoria Needed to Justify Valuation

Ascletis Pharma Inc (AP HK) which specialises in developing drugs to treat HCV (hepatitis C virus), HIV and liver cancer, is the first pre-profit...

Logo
1k Views
Share
bullish•Legend Holdings
•07 Jun 2018 16:38

Legend's Conversion of Domestic Shares

Yesterday, a CCASS filing highlighted 850mn shares entering Legend Holdings Corp H (3396 HK)'s share registry via CCASS Participant ID A00002, as...

Logo
608 Views
Share
•29 Jan 2018 03:44

Quiddity Weekly H/A: Discounts & Southbound Flows 20180126

This is a new H/A Spread monitor project offering a brief look at recent changes in H-Share and A-Share spreads, Southbound flow and impact, and...

Logo
531 Views
Share
x